Doximity DOCS reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of 38 cents, which beat the Zacks ...

Shares of Doximity plummeted late Thursday after the telehealth software company dished out a disappointing outlook.

Doximity faces flat growth, competitive pressure, and overvaluation, making it a potential short with a $45 target. Click ...

Doximity's Q4 performance likely witnessed strong product ... holding steady at $58. However, the stock is beating the S&P 500’s 6.2% decline during that period. Doximity (DOCS) concluded ...

Investors will be eagerly watching for the performance of Doximity in its upcoming earnings ... changes are directly correlated with near-term stock prices. To benefit from this, we have developed ...

Doximity’s stock fell sharply in aftermarket trading, dropping 23.44% to $44.75. Doximity demonstrated robust financial performance in Q4 FY2025, with revenue growing 17% year-over-year to $138 ...

Despite these positive results, Doximity’s stock fell sharply in aftermarket trading, dropping 23.44% to $44.75. Doximity demonstrated robust financial performance in Q4 FY2025, with revenue growing ...

Doximity reported fourth-quarter fiscal 2025 ... shares of DOCS plunged 20.7% during after-hours trading on May 15. The stock fell 9.5% year to date compared with a 6.2% decline in the industry.